Views & Analysis

Oncology
CAR-TCR 2023 – Becky Cap

CAR-TCR 2023 – Becky Cap

In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder

Oncology
CAR-TCR 2023 – Jason Noon

CAR-TCR 2023 – Jason Noon

If we learned anything at CAR-TCR it’s that CAR-T therapies are still a relatively new treatment modality and innovation is happening along many different axes.

Oncology
Economist Brussels Day 2

9th Annual World Cancer Series: Day 2

As Economist Impact’s World Cancer Series continues, Day Two firmly takes up focus on the patient voice, with a presentation by Eileen Page, chief executive of Innovation Advantage 2020 to